We have located links that may give you full text access.
Beta-HCG Secretion by a Pulmonary Choriocarcinoma in a Male Patient.
BACKGROUND: Paraneoplastic secretion of beta-subunit of human chorionic gonadotropin ( β -HCG) in pulmonary carcinoma is rare. Case Presentation . A 65-year-old man presented with bilateral gynaecomastia with abnormally high levels of β -hCG and elevated oestradiol, progesterone, and testosterone levels on April 7, 2023. After excluding testicular malignancy, CT scan of the chest and abdomen revealed bilateral pulmonary lesions. Transthoracic biopsy confirmed malignancy with choriocarcinoma. MRI of the brain showed a solitary brain metastasis, while on a subsequent 18F-FDG PET/CT, no other metastatic lesions were seen. The patient was treated with chemoimmunotherapy carboplatin-etoposide-pembrolizumab with good partial response.
CONCLUSION: Our case of a presumably stage IV dedifferentiated mNSCLC presenting as an extragonadal β -hCG secreting pulmonary choriocarcinoma is a very rare tumor with a poor prognosis. Its biology, origin, and treatment remain to be elucidated. Cancer genome sequencing is necessary for the identification of the origin and seeking treatment.
CONCLUSION: Our case of a presumably stage IV dedifferentiated mNSCLC presenting as an extragonadal β -hCG secreting pulmonary choriocarcinoma is a very rare tumor with a poor prognosis. Its biology, origin, and treatment remain to be elucidated. Cancer genome sequencing is necessary for the identification of the origin and seeking treatment.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app